Genome-wide association study in patients with pulmonary Mycobacterium avium complex disease

Rationale Nontuberculous mycobacteria (NTM) are environmental mycobacteria that can cause a chronic progressive lung disease. Although epidemiological data indicate potential genetic predisposition, its nature remains unclear. Objectives We aimed to identify host susceptibility loci for Mycobacterium avium complex (MAC), the most common NTM pathogen. Methods This genome-wide association study (GWAS) was conducted in Japanese patients with pulmonary MAC and healthy controls, followed by genotyping of candidate single-nucleotide polymorphisms (SNPs) in another Japanese cohort. For verification by Korean and European ancestry, we performed SNP genotyping. Results The GWAS discovery set included 475 pulmonary MAC cases and 417 controls. Both GWAS and replication analysis of 591 pulmonary MAC cases and 718 controls revealed the strongest association with chromosome 16p21, particularly with rs109592 (p=1.64×10−13, OR 0.54), which is in an intronic region of the calcineurin-like EF-hand protein 2 (CHP2). Expression quantitative trait loci analysis demonstrated an association with lung CHP2 expression. CHP2 was expressed in the lung tissue in pulmonary MAC disease. This SNP was associated with the nodular bronchiectasis subtype. Additionally, this SNP was significantly associated with the disease in patients of Korean (p=2.18×10−12, OR 0.54) and European (p=5.12×10−03, OR 0.63) ancestry. Conclusions We identified rs109592 in the CHP2 locus as a susceptibility marker for pulmonary MAC disease. The first GWAS of pulmonary MAC disease in Japanese, Korean and European patients. SNPs in the CHP2 region were associated with the disease risk. CHP2 may play an important role in host susceptibility to pulmonary MAC disease. https://bit.ly/39iCIio

[1]  H. Tettelin,et al.  Whole‐Exome Sequencing Identifies the 6q12‐q16 Linkage Region and a Candidate Gene, TTK, for Pulmonary Nontuberculous Mycobacterial Disease , 2017, American journal of respiratory and critical care medicine.

[2]  R. Diel,et al.  Pulmonary disease by non-tuberculous mycobacteria – clinical management, unmet needs and future perspectives , 2017, Expert review of respiratory medicine.

[3]  K. Tokunaga,et al.  The first genome-wide association study identifying new susceptibility loci for obstetric antiphospholipid syndrome , 2017, Journal of Human Genetics.

[4]  S. Holland,et al.  MPEG1/perforin-2 mutations in human pulmonary nontuberculous mycobacterial infections. , 2017, JCI insight.

[5]  P. Price,et al.  A haplotype spanning P2X7R, P2X4R and CAMKK2 may mark susceptibility to pulmonary non-tuberculous mycobacterial disease , 2017, Immunogenetics.

[6]  F. Blasi,et al.  Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis , 2016, International journal of molecular sciences.

[7]  Satoshi Mitarai,et al.  Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan , 2016, Emerging infectious diseases.

[8]  Masao Nagasaki,et al.  iJGVD: an integrative Japanese genome variation database based on whole-genome sequencing , 2015, Human Genome Variation.

[9]  A. Garcia-Basteiro,et al.  Non-tuberculous mycobacteria in children: muddying the waters of tuberculosis diagnosis. , 2015, The Lancet. Respiratory medicine.

[10]  C. Fernández-Hernando,et al.  Protein kinase C isoforms in atherosclerosis: pro- or anti-inflammatory? , 2014, Biochemical pharmacology.

[11]  S. Grinstein,et al.  Na+/H+ exchangers. , 2011, Comprehensive Physiology.